Researchers at University College Cork in Ireland have developed a patch that delivers small doses of a vaccine through microscopic needles

UCC Developing Vaccine Patch To Combat Malaria

Researchers at University College Cork in Ireland have developed a patch that delivers small doses of a vaccine through microscopic needles A new malaria vaccine administered through a micro-needle patch has been developed by scientists at the school of pharmacy at the University College Cork in Ireland. The patch itself is composed of microscopic silicon needles which deliver the vaccine …

GSK announces EU regulatory submission for malaria vaccine candidate RTS,S

July 24, 2014 GSK announced today that it has submitted a regulatory application to the European Medicines Agency (EMA) for its malaria vaccine candidate, RTS,S. The submission will follow the Article 58 procedure, which allows the EMA to assess the quality, safety and efficacy of a candidate vaccine, or medicine, manufactured in a European Union (EU) member state, for a …

ExxonMobil Marks World Malaria Day With $10 Million in New Grants

Increased funding to support partnerships with nearly 20 organizations fighting malaria ExxonMobil has committed more than $120 million to fighting malaria, reaching more than 105 million people Partnerships helped distribute more than 13 million bed nets, administer 2 million malaria treatments and train 355,000 health workers April 25, 2014 ExxonMobil marked World Malaria Day today by participating in events across Africa …

World Malaria Day 2014: New Vaccine Candidates Against Malaria Enter Clinical Development

European Vaccine Initiative supports international consortia in their quest for malaria vaccines April 22, 2014 Under the coordination of the European Vaccine Initiative (EVI), sixteen projects are devoted to the acceleration of malaria vaccine development of which two novel vaccine candidates recently received ethical and regulatory approval to start clinical development. The two new vaccine candidates – called P27A and …

Waiting for a Malaria Vaccine: Strengthening the supply chain

With potential malaria vaccines just a couple of years away, there’s a real need to start looking at whether the supply chains found in the developing world will be able to support the sort of mass roll-out that we would expect for a vaccine that has the potential to save millions of lives each year. With organisations such as the …

Phase 1 Clinical Trial Begins for Malaria Vaccine Candidate Based on iBio’s Proprietary Technology

February 10th, 2014 iBio, Inc., a leader in plant-based biotechnology for developing and manufacturing biological products, reported the initiation of a Phase 1 human safety and immunogenicity clinical study of a transmission-blocking malaria vaccine candidate. The vaccine candidate was produced on the company’s proprietary iBioLaunch™ platform by the Fraunhofer USA Center for Molecular Biotechnology. The text describing the program, released …

What’s the link between algae and malaria?

We all know of the link between malaria and watery habitats – but scientists have been looking at another link between the mosquito-borne disease and pond-dwelling photosynthetic blooms. The malaria parasite produces very complex, 3D proteins that are difficult and expensive to reproduce in traditional recombinant systems. Hence researchers have been looking for cheaper ways to produce these proteins, but …

Why a malaria vaccine? Novel T cell antigen discovery technology and malaria vaccines

Why a Malaria Vaccine? The 2011 WHO World Malaria Report estimated 655,000 malaria deaths and 216 million clinical cases in 2010 alone. Malaria remains a global problem, despite the use of preventive actions, such as the use of nets, anti-malarial drugs and insecticides. Malaria Prevention is a top priority and subsequently, so is the development of a vaccine. Dr Jessica …